التفاصيل البيبلوغرافية
| العنوان: |
A Phase 1, Open-Label, Dose Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of a first in class Pol1 inhibitor (CX-5461) in Patients with Advanced Haematologic Malignancies (HM) |
| المؤلفون: |
Khot, A., Brajanovski, N., Cameron, D., Hein, N., McArthur, G.A., Lim, J.K.C., O'Brien, S.E., Ryckman, D., Yu, G.I., Link, E., Donohoe, C., Snowden, A., Hannan, R., Harrison, S.J. |
| المصدر: |
In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e280-e281 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder